DuPont will pay a fine of $1.275M to settle a federal complaint over eight chemical releases from a Kanawha County production facility, one of which killed a worker. The Department of Justice and U.S. Environmental Protection Agency said the settlement announced in a statement Wednesday resolves several alleged violations of federal law.
One of Japan’s leading research institutions, the prestigious Riken Institute, will scale down...
Allergan to Request Court Block Valeant and Pershing Square from Voting Shares Acquired in Violation of Insider Trading LawsAugust 27, 2014 8:27 am | News | Comments
Allergan has asked the United States District Court for the Central District of California to...
Business isn't buying the Alabama Supreme Court's attempt to limit the fallout from its decision saying brand-name drugmakers can be held liable for warnings on generic medication produced by other companies. A majority of justices signed off on an opinion that went to lengths last week to say...
The prison agency in the nation's busiest death penalty state paid $13,500 for its most recent batch of pentobarbital at a cost of $1,500 per vial, compared to $350 per dose spent last year.
Sabahaddin Akman, owner of the Istanbul, Turkey, firm Ozay Pharmaceuticals, has pleaded guilty to charges of smuggling misbranded and adulterated cancer treatment drugs into the United States.
A freeze on capital punishment in Ohio will continue into 2015 after a federal judge extended a months-long moratorium on executions as questions mount about the effectiveness of a new, two-drug combination being used to carry out the death penalty.
The wealthy businessman who lavished former Virginia Gov. Bob McDonnell and his wife with thousands of dollars in gifts and loans said repeatedly that the couple supported his company and its signature product, former state Attorney General Jerry Kilgore testified Monday.
McKesson Corp. was required to ensure vaccines were maintained at proper temperatures by, among other things, setting electronic temperature monitors to detect when air temperature in the box reached certain levels.
Patient advocates say some insurance companies are making HIV and AIDS drugs unaffordable in plans issued through the Affordable Care Act by shifting much of the cost to customers. While the issue applies broadly to all patients with chronic illnesses that require expensive medication, HIV and AIDS advocates say they were the first to file a formal complaint with the government about pricing.
Mallinckrodt today announced that its subsidiary, Cadence Pharmaceuticals, Inc., has entered into settlement and license agreements with Fresenius Kabi USA, LLC, resolving pending patent litigation involving OFIRMEV ® (acetaminophen) injection.
Pfizer will pay $35 million to resolve allegations by 42 states that its subsidiary, Wyeth Pharmaceuticals, illegally marketed an organ transplant drug for unapproved uses. The states' attorneys general said Wednesday that Wyeth, which Pfizer bought in 2009, trained sales representatives to prescribe Rapamune for uses other than preventing rejection of transplanted kidneys.
Chinese regulators have launched a series of anti-monopoly investigations of foreign automakers and technology providers, stepping up pressure on foreign companies that feel increasingly unwelcome in China.
Federal investigators warn of the growing problem of "dirty doctors," who prescribe highly-addictive painkillers for cash.
Allergan Inc.'s lawsuit, filed Friday in U.S. District Court in Santa Ana, California, names as plaintiffs drugmaker Valeant Pharmaceuticals International Inc., New York investment and hedge fund firm Pershing Square Capital Management LP and its principal, William Ackerman.
Bob McDonnell headed back to court Thursday over federal corruption charges alleging that he and his wife accepted more than $165,000 in gifts, lavish trips, and cash in exchange for promoting dietary supplements.
Idaho prison officials say they had to have thousands of dollars' worth of medications shipped overnight to the state's largest prison after the former operator, Corrections Corporation of America, left the facility without a promised eight-day supply of inmate drugs.
A Shanghai court says American and British investigators who worked for drug maker GlaxoSmithKline will stand trial Aug. 8 on charges of illegally obtaining information on Chinese citizens. The Shanghai No. 1 Intermediate People's Court said Tuesday that Yingzeng Yu and her husband Peter Humphrey will have a "public trial."
A third execution by lethal injection has gone awry in six months, renewing debate over whether there is a foolproof way for the government to humanely kill condemned criminals, and whether it's even worth looking for one.
Staking out a populist stand ahead of the midterm elections, President Barack Obama on Thursday demanded "economic patriotism" from U.S. corporations that use legal means to avoid U.S. taxes through overseas mergers.
Humans are a strange lot. We are more than willing to believe just about any product claim in the hopes that an easy solution to our problem can be found inside a pill, tablet or liquid.
The Oregon lawsuit filed Thursday in Portland contends 5-Hour Energy falsely claims customers get extra energy and focus from a unique blend of ingredients, when the boost actually comes from a concentrated dose of caffeine.
Chinese authorities formally indicted two corporate investigators, an American and Briton, for allegedly illegally obtaining and selling private information, state media reported Monday. Prosecutors in Shanghai filed charges against British investigator Peter Humphrey and his wife Yingzeng Yu, a U.S. citizen, at the city's No. 1 Intermediate People's Court, the official Xinhua News Agency said.
Two years after a deadly nationwide meningitis outbreak linked to a compounding pharmacy in Massachusetts, Gov. Deval Patrick on Thursday signed a law he said would address a "gray area" between state and federal oversight of the pharmacies.
Neurelis has announced an agreement with Biotie Therapies to end the option held by Biotie to purchase Neurelis, clearing the way for Neurelis to commence further development of NRL-1 for pediatric and adult epilepsy patients who experience acute repetitive seizures.
A pharmacist who oversaw a major hospital's vault of drugs stole nearly 200,000 powerful painkillers he was supposed to safeguard and dispense, narcotics prosecutors said Tuesday as they unveiled a case that makes unusual use of a state drug-kingpin law.
The European Union's antitrust body is imposing a fine of 428 million euros ($580 million) on France's pharmaceutical company Servier and five producers of generic medicines for distorting competition.
A U.S. Embassy spokesman says diplomats are barred from the trial in Shanghai of an American investigator for GlaxoSmithKline and her British husband who are charged with improperly selling personal information. Spokesman Nolan Barkhouse said Friday that the U.S. government is concerned about lack of access to the trial of Yu Yingzeng and husband Peter Humphrey in August.
- Page 1